BR9610530A - Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos - Google Patents

Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos

Info

Publication number
BR9610530A
BR9610530A BR9610530A BR9610530A BR9610530A BR 9610530 A BR9610530 A BR 9610530A BR 9610530 A BR9610530 A BR 9610530A BR 9610530 A BR9610530 A BR 9610530A BR 9610530 A BR9610530 A BR 9610530A
Authority
BR
Brazil
Prior art keywords
same
pharmaceutical compositions
compositions containing
heteroaryl substituted
derivatives
Prior art date
Application number
BR9610530A
Other languages
English (en)
Inventor
Kazumi Kikuchi
Akira Toyoshima
Toshio Okazaki
Masahiro Takanashi
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of BR9610530A publication Critical patent/BR9610530A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9610530A 1995-09-20 1996-09-19 Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos BR9610530A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24171695 1995-09-20
PCT/JP1996/002696 WO1997011055A1 (fr) 1995-09-20 1996-09-19 Derives d'acryloylguanidine a substitution heteroaryle et leurs composition medicinale

Publications (1)

Publication Number Publication Date
BR9610530A true BR9610530A (pt) 1999-07-06

Family

ID=17078479

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610530A BR9610530A (pt) 1995-09-20 1996-09-19 Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos

Country Status (13)

Country Link
EP (1) EP0861831A4 (pt)
KR (1) KR19990063589A (pt)
CN (1) CN1196721A (pt)
AU (1) AU702092B2 (pt)
BR (1) BR9610530A (pt)
CA (1) CA2232497A1 (pt)
CZ (1) CZ84098A3 (pt)
HU (1) HUP9901336A3 (pt)
NO (1) NO981241L (pt)
PL (1) PL326033A1 (pt)
SK (1) SK35198A3 (pt)
WO (1) WO1997011055A1 (pt)
ZA (1) ZA967800B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515854A (ja) * 1995-08-02 2002-05-28 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗薬
CA2283404A1 (en) * 1997-03-06 1998-09-11 Jun Sasamori Cycloalka¬b|pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
JP2003507468A (ja) * 1999-08-23 2003-02-25 スミスクライン・ビーチャム・コーポレイション 脂肪酸シンターゼ阻害剤
WO2002051441A1 (fr) 2000-12-26 2002-07-04 Sankyo Company, Limited Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline
ATE444962T1 (de) 2004-06-16 2009-10-15 Wyeth Corp Amino-5,5-diphenylimidazolon-derivate zur beta- sekretase-hemmung
MXPA06014792A (es) 2004-06-16 2007-02-16 Wyeth Corp Difenilimidazopirimidina y aminas imidazol como inhibidores de ??-secretasa.
BRPI0606690A2 (pt) 2005-01-14 2009-07-14 Wyeth Corp composto; uso do composto para o tratamento de uma doença ou distúrbio associado com uma atividade excessiva de bace; e composição farmacêutica
EP1844035A1 (en) 2005-02-01 2007-10-17 Wyeth Amino-pyridines as inhibitors of beta-secretase
WO2006088694A1 (en) 2005-02-14 2006-08-24 Wyeth SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
AU2006214627A1 (en) 2005-02-14 2006-08-24 Wyeth Azolylacylguanidines as beta-secretase inhibitors
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
AU2006266167A1 (en) 2005-06-30 2007-01-11 Wyeth Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
CA2623245A1 (en) 2005-09-26 2007-04-05 Wyeth Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
WO2007100536A1 (en) 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
AR065814A1 (es) 2007-03-23 2009-07-01 Wyeth Corp Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados.
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
JP3162572B2 (ja) * 1993-04-28 2001-05-08 住友製薬株式会社 インドロイルグアニジン誘導体
US5401758A (en) * 1993-10-07 1995-03-28 Bristol-Myers Squibb Company Pyridinyl cyanoguanidine compounds
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
JPH0959245A (ja) * 1995-08-25 1997-03-04 Yamanouchi Pharmaceut Co Ltd N−(2−プロペノイル)グアニジン誘導体

Also Published As

Publication number Publication date
ZA967800B (en) 1997-04-03
WO1997011055A1 (fr) 1997-03-27
HUP9901336A3 (en) 2000-02-28
SK35198A3 (en) 1999-06-11
EP0861831A4 (en) 1998-11-11
EP0861831A1 (en) 1998-09-02
KR19990063589A (ko) 1999-07-26
PL326033A1 (en) 1998-08-17
CZ84098A3 (cs) 1998-09-16
NO981241L (no) 1998-05-20
AU7000796A (en) 1997-04-09
MX9802238A (es) 1998-08-30
CA2232497A1 (en) 1997-03-27
NO981241D0 (no) 1998-03-19
CN1196721A (zh) 1998-10-21
HUP9901336A2 (hu) 1999-08-30
AU702092B2 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
NO962606L (no) Farmasöytisk sammensetning
IS4706A (is) Lyfjasamsetningar
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
BR9611367A (pt) Formulação farmacêutic liofilizada estável
FI955144A (fi) Päällystetyt farmaseuttiset koostumukset
FI944832A0 (fi) Farmaseuttinen koostumus
IL117962A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
BR9610396A (pt) Formulação farmacêutica
BR9610530A (pt) Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos
ITMI932540A0 (it) Composizione farmaceutica
DE69614407D1 (de) Pharmazeutische zusammensetzungen
LV11727A (lv) Farmaceitiska kompozicija
FI973229A (fi) Uusi farmaseuttinen koostumus
BR9507768A (pt) Composição farmacêutica
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.
FI973280A (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973230A (fi) Uusi farmaseuttinen formulaatio
LV10579A (lv) Farmaceitiska kompozicija
BR9606066A (pt) Composto e formulação farmacêutica
BR9307182A (pt) Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
BR9605777A (pt) Composição farmacêutica
FI962738A (fi) Farmaseuttiset koostumukset

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law